Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.

CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.

Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.

Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.

Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.

Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.

“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.

Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.

PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.

Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.

• ·[KH Explains] China ups OLED ante to take over Korean shares
• ·LG Display to cut jobs in cost
• ·Seoul shares open lower on US tech slide
• ·조응천 "8년간 쓴소리 했는데…요즘은 백태클에 뒤통수 가격"
• ·Succession scheme taking shape at Lotte
• ·[사진] 부산 깡통시장 간 윤 대통령과 기업 총수들
• ·Passengers file complaints over burning smell on Gimpo Goldline
• ·Court overturns ruling on fabricated asylum interview: report
• ·Mirae Asset Securities names new CEOs
• ·[KH Explains] Banks, regulators trade blame for snowballing ELS losses
• ·S. Korea asks UAE to correct nat'l flag image mix
• ·S. Korea, US, Japan to discuss regional security issues: White House
• ·안철수 “이준석 신당 성공 가능성 낮아…3가지 갖추지 못해“
• ·LG H&H sales up 294% in half year on Japan's Qoo10
• ·Posco Future M to supply battery materials for LG
• ·S. Korea asks UAE to correct nat'l flag image mix